Dissecting the loci of low‐level quinine resistance in malaria parasites

Molecular Microbiology - Tập 52 Số 4 - Trang 985-997 - 2004
Michael T. Ferdig1, Roland A. Cooper2,3,1, Jianbing Mu1, Bingbing Deng4, Deirdre A. Joy1, Xin‐zhuan Su1, Thomas E. Wellems1
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 126, NIH Campus, Bethesda, MD 20892‐0425, USA.
2Department of Biological Sciences, Old Dominion University, Norfolk, VA, USA
3Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
4Dept. of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA

Tóm tắt

SummaryQuinine (QN) remains effective against Plasmodium falciparum, but its decreasing efficacy is documented from different continents. Multiple genes are likely to contribute to the evolution of QN resistance. To locate genes contributing to QN response variation, we have searched a P. falciparum genetic cross for quantitative trait loci (QTL). Results identify additive QTL in segments of chromosomes (Chrs) 13, 7 and 5, and pairwise effects from two additional loci of Chrs 9 and 6 that interact, respectively, with the QTL of Chrs 13 and 7. The mapped segments of Chrs 7 and 5 contain pfcrt, the determinant of chloroquine resistance (CQR), and pfmdr1, a gene known to affect QN responses. Association of pfcrt with a QTL of QN resistance supports anecdotal evidence for an evolutionary relationship between CQR and reduced QN sensitivity. The Chr 13 segment contains several candidate genes, one of which (pfnhe‐1) encodes a putative Na+/H+ exchanger. A repeat polymorphism in pfnhe‐1 shows significant association with low QN response in a collection of P. falciparum strains from Asia, Africa and Central and South America. Dissection of the genes and modifiers involved in QN response will require experimental strategies that can evaluate multiple genes from different chromosomes in combination.

Từ khóa


Tài liệu tham khảo

10.1086/320195

10.4269/ajtmh.1992.47.521

Bickii J., 1998, Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates, J Clin Microbiol, 36, 243, 10.1128/JCM.36.1.243-247.1998

10.4269/ajtmh.1992.46.8

10.1016/S0163-7258(97)00083-1

10.1083/jcb.145.2.363

10.1128/AAC.47.11.3500-3505.2003

10.1093/genetics/138.3.963

10.1001/jama.213.12.2041

10.1124/mol.61.1.35

10.1073/pnas.91.3.1143

10.1128/AAC.16.6.710

10.1056/NEJM200101253440403

10.1111/j.1744-7348.1987.tb03230.x

10.1017/S0031182099004953

10.1016/S1097-2765(05)00077-8

10.1104/pp.125.1.437

10.1038/263767a0

James S.P., 1932, A study of induced malignant tertian malaria, Proc Roy Soc Med, 25, 1153, 10.1177/003591573202500801

Jelinek T., 1995, Quinine resistant falciparum malaria acquired in east Africa, Trop Med Parasitol, 46, 38

10.1016/0166-6851(93)90048-3

10.1006/geno.2001.6569

10.1126/science.3317830

10.1093/genetics/121.1.185

10.1038/ng1195-241

10.4269/ajtmh.1993.48.739

10.1126/science.3544220

10.1046/j.1365-2958.2003.03627.x

10.1055/s-0028-1143000

10.1016/0014-4894(88)90082-3

10.1074/jbc.272.36.22373

10.1101/gr.5.4.321

10.1128/AAC.47.8.2418-2423.2003

10.1016/0035-9203(94)90102-3

10.1038/35002615

10.1016/S0092-8674(00)81127-7

10.1590/S0036-46651997000200004

10.1093/genetics/159.1.371

10.1126/science.1074045

10.1016/0035-9203(86)90290-7

10.1038/416326a

10.1126/science.286.5443.1351

10.1126/science.781840

10.1016/0035-9203(91)90343-W

10.1086/322858

10.1038/345253a0

10.1016/S0092-8674(00)81471-3

10.1038/nature00813

10.1016/S0035-9203(00)90300-6

10.1083/jcb.140.2.335

10.4269/ajtmh.1998.58.630